[Immunologic response in patients with melanoma of the skin]. 1983

A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova

Immunologic vigor was studied in 108 patients with skin melanoma and 20 healthy subjects by time-delayed hypersensitivity skin and leukocyte adherence inhibition tests. A correlation between changes in immune response and the clinical picture of melanoma was established. During remission immunologic indexes became stabilized in most patients. As tumor progressed, immune response deteriorated markedly, blood serum developed a blocking effect and promoted leukocyte adherence. Healthy subjects who were in close contact with melanoma, showed positive reaction in leukocyte adherence inhibition test with melanoma tissue extract.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007957 Leukocyte Adherence Inhibition Test Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor. LAI Test,LAI Tests,Test, LAI,Tests, LAI
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
September 1977, Transactions of the ophthalmological societies of the United Kingdom,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
October 1987, Lijecnicki vjesnik,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
December 1989, Bratislavske lekarske listy,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
January 1975, Voprosy onkologii,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
March 2023, Non-coding RNA research,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
April 1970, Surgery,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
December 1969, British journal of cancer,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
June 1965, Archives of dermatology,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
December 1988, Seminars in oncology,
A Ia Mutsenietse, and A A Volrat, and B A Popena, and Ia V Bumbieris, and E A Shapovalova
July 1973, Journal of the National Cancer Institute,
Copied contents to your clipboard!